Llombart-Cussac, A., Perez-Garcia, J., Borrego, M., Tolosa, P., Blanch, S., Fernandez-Ortega, A., . . . Cortes, J. (2024). Preventing alpelisib-related hyperglycaemia in HR+/HER2-/ <i>PIK3</i>CA-mutated advanced breast cancer using metformin (METALLICA): A multicentre, open-label, single-arm, phase 2 trial.
Chicago Style CitationLlombart-Cussac, A., et al. Preventing Alpelisib-related Hyperglycaemia in HR+/HER2-/ <i>PIK3</i>CA-mutated Advanced Breast Cancer Using Metformin (METALLICA): A Multicentre, Open-label, Single-arm, Phase 2 Trial. 2024.
MLA CitationLlombart-Cussac, A., et al. Preventing Alpelisib-related Hyperglycaemia in HR+/HER2-/ <i>PIK3</i>CA-mutated Advanced Breast Cancer Using Metformin (METALLICA): A Multicentre, Open-label, Single-arm, Phase 2 Trial. 2024.